Since we earlier showed that legumain expression is post-transcriptionally downregulated by miR-3978 in normal peritoneum and is deregulated during metastatic progression (Zhang et al., 2016), we were interested in defining the post-transcriptional landscape during peritoneal metastasis progression of gastric cancer. The gene discussed is LGMN; the disease is gastric cancer.